In the last week alone, a total of five companies, three pharmaceuticals - Cadila Healthcare, Natco Pharma and Shilpa Medicare –and Sarla Performance Fibers and Associate Stone Industries (Kotah) have announced the split of face value of their equity shares as these stocks are quoting at multi-year highs.
Cadila Healthcare and Associated Stone Industries (Kotah) have approved the sub-division of equity shares of their companies from Rs 5 to Rs 1. Natco Pharma will split the face value of its equity shares from Rs 10 to Rs 2, Sarla Performance Fibres from Rs 10 to Re 1 and Shilpa Medicare from Rs 2 into Re 1.
A stock split is usually done by companies that have seen their share price increase to levels that are either too high or beyond the price levels of similar companies in their sector.
The primary motive is to make shares seem more affordable to small investors even though the underlying value of the company has not changed.
Signet Industries has turned ex-stock split today. The company sub-divided the equity shares in the ratio of 10:1 i.e. ten equity shares of Re 1 each for every one equity share of Rs 10 each held.
Signet Industries has zoomed nearly 200% thus far in 2015 from Rs 12.85 to Rs 38 (adjusted to stock split) on the BSE.
"Stock split increases the quantum of floating stocks. As the value goes down, more investors buy stocks," said an analyst.
Ajanta Pharma, Granules India, JMT Auto, Rollatainers and Rasi Electrodes are some shares that have rallied more than 20% post stock split. However, Tech Mahindra, Tata Coffee, Corporation Bank and Bank of Baroda are among notable stocks that declined 6%-34% after sub-division of shares.
Meanwhile, in the first seven-and-half months of calendar year 2015, as many as 56 companies announced stock splits. Of these, 49 companies have split their shares, while seven others have proposed to do so.
In 2014, 35 companies had opted for stock splits during the same period. About 82 companies had sub-divided face value of their equity shares in entire previous calendar year 2014, according to Capitaline data.
| Price on BSE in Rs | |||
| Company | 31 Dec,14 | 14 Aug,15 | %chg |
| Associated Stone | 44.95 | 106.40 | 136.7 |
| Kushal Tradelink | 76.50 | 153.00 | 100.0 |
| ITD Cem | 493.05 | 808.00 | 63.9 |
| Shilpa Medicare | 712.90 | 1051.85 | 47.5 |
| Natco Pharma | 1530.65 | 2130.80 | 39.2 |
| Sarla Performance Fibres | 438.50 | 609.75 | 39.1 |
| Cadila Healthcare | 1598.35 | 1985.70 | 24.2 |
| S&P BSE Sensex | 27499.42 | 28067.31 | 2.1 |
| Performance of the companies that proposed to stock split | |||
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)